{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:24Z","timestamp":1792785864637,"version":"4.5.0"},"reference-count":115,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270559"],"award-info":[{"award-number":["82270559"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070572"],"award-info":[{"award-number":["82070572"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFD044"],"award-info":[{"award-number":["2023AFD044"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Interdisciplinary Research Support Program of Huazhong University of Science and Technology","award":["2025JCYJ069"],"award-info":[{"award-number":["2025JCYJ069"]}],"id":[{"id":"https:\/\/ror.org\/00p991c53","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background &amp; Aims<\/jats:title>\n                    <jats:p>The treatment of inflammatory bowel disease faces a persistent efficacy ceiling, with approximately 30%-50% of patients failing to achieve or sustain remission with current biologics and small-molecule inhibitors. This challenge is partly attributable to profound mucosal heterogeneity. Single-cell and spatial multi-omics technologies have enabled this heterogeneity to be characterized at cellular and spatial resolution. We aimed to synthesize single-cell and spatial multi-omics evidence to clarify the cellular mechanisms underlying therapeutic response and resistance and their implications for precision therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined single-cell evidence across therapies targeting tumor necrosis factor, integrins, interleukin-12\/23, and Janus kinases and organized the findings around three interacting cellular hallmarks: immune dysregulation, stromal remodeling, and epithelial reprogramming.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Single-cell and spatial multi-omics studies indicate that therapeutic efficacy may depend on the capacity to remodel multicellular communication networks rather than simply neutralizing individual molecular targets. Treatment resistance is associated with bypass pathway activation, drug-induced paradoxical reprogramming and pathogenic subset enrichment, and alternative homing routes. Predictive models link multicellular modules, dynamic gene expression signatures, and multi-omics integration frameworks to treatment outcomes and may facilitate the development of clinically accessible patient-stratification tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings support a cellular ecosystem framework for understanding therapeutic response and resistance in inflammatory bowel disease. Translating this framework into precision care will require functional validation of candidate mechanisms and prospective clinical evaluation of predictive tools for treatment selection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjag136","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:42:45Z","timestamp":1787658165000},"source":"Crossref","is-referenced-by-count":0,"title":["Single-cell insights into drug response and resistance in inflammatory bowel disease: cellular hallmarks and precision therapy"],"prefix":"10.1093","volume":"20","author":[{"given":"Chunshan","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan\u00a0430022,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan\u00a0430022,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanke","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan\u00a0430022,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8878-3131","authenticated-orcid":false,"given":"Yu","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan\u00a0430022,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2026091717151058500_jjag136-B1","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41575-025-01097-1","article-title":"The global burden of inflammatory bowel disease: from 2025 to 2045","volume":"22","author":"Kaplan","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S2468-1253(16)30077-2","article-title":"Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China","volume":"1","author":"Kaplan","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41573-024-00953-0","article-title":"Navigating the complexities of drug development for inflammatory bowel disease","volume":"23","author":"Honap","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"2026091717151058500_jjag136-B4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.dld.2023.06.009","article-title":"Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: meta-analysis","volume":"56","author":"Barberio","year":"2024","journal-title":"Dig Liver Dis"},{"key":"2026091717151058500_jjag136-B5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/ecco-jcc\/jjz162","article-title":"Therapeutic drug monitoring of biologics during induction to prevent primary non-response","volume":"14","author":"Sparrow","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026091717151058500_jjag136-B6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.cgh.2019.03.037","article-title":"Appropriate therapeutic drug monitoring of biologic agents for patients with inflammatory bowel diseases","volume":"17","author":"Papamichael","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.trsl.2015.09.002","article-title":"Pathway-based approaches to the treatment of inflammatory bowel disease","volume":"167","author":"Bamias","year":"2016","journal-title":"Transl Res"},{"key":"2026091717151058500_jjag136-B8","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/ecco-jcc\/jjab085","article-title":"Immunological networks defining the heterogeneity of inflammatory bowel diseases","volume":"15","author":"Selin","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2026091717151058500_jjag136-B9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/gutjnl-2023-330000","article-title":"Rise of precision medicine: can it deliver on its promise in IBD?","volume":"75","author":"Schreiber","year":"2025","journal-title":"Gut"},{"key":"2026091717151058500_jjag136-B10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S2468-1253(18)30265-6","article-title":"Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease","volume":"3","author":"Atreya","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S2468-1253(24)00044-X","article-title":"Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study","volume":"9","author":"Chanchlani","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B12","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1136\/gutjnl-2024-334165","article-title":"Single-cell omics in inflammatory bowel disease: recent insights and future clinical applications","volume":"74","author":"Gudi\u00f1o","year":"2025","journal-title":"Gut"},{"key":"2026091717151058500_jjag136-B13","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/ibd\/izaa089","article-title":"Inflammatory bowel disease through the lens of single-cell RNA-seq technologies","volume":"26","author":"Corridoni","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2026091717151058500_jjag136-B14","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1016\/j.cell.2025.06.009","article-title":"A clinical road map for single-cell omics","volume":"188","author":"Skinnider","year":"2025","journal-title":"Cell"},{"key":"2026091717151058500_jjag136-B15","doi-asserted-by":"publisher","first-page":"1794207","DOI":"10.3389\/fimmu.2026.1794207","article-title":"Understanding heterogeneity in the pathogenesis and drug responses of ulcerative colitis through single-cell and spatial transcriptomics","volume":"17","author":"Phillips","year":"2026","journal-title":"Front Immunol"},{"key":"2026091717151058500_jjag136-B16","doi-asserted-by":"publisher","first-page":"1073984","DOI":"10.1155\/2023\/1073984","article-title":"Intestinal immune imbalance is an alarm in the development of IBD","volume":"2023","author":"Hu","year":"2023","journal-title":"Mediators Inflamm"},{"key":"2026091717151058500_jjag136-B17","doi-asserted-by":"publisher","first-page":"eabb4432","DOI":"10.1126\/sciimmunol.abb4432","article-title":"Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses","volume":"5","author":"Boland","year":"2020","journal-title":"Sci Immunol"},{"key":"2026091717151058500_jjag136-B18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1053\/j.gastro.2024.01.007","article-title":"The FOXP3+ pro-inflammatory T cell: a potential therapeutic target in Crohn\u2019s disease","volume":"166","author":"Kosinsky","year":"2024","journal-title":"Gastroenterology"},{"key":"2026091717151058500_jjag136-B19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","article-title":"Intra- and inter-cellular rewiring of the human colon during ulcerative colitis","volume":"178","author":"Smillie","year":"2019","journal-title":"Cell"},{"key":"2026091717151058500_jjag136-B20","doi-asserted-by":"publisher","first-page":"1161901","DOI":"10.3389\/fimmu.2023.1161901","article-title":"The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population","volume":"14","author":"Medina","year":"2023","journal-title":"Front Immunol"},{"key":"2026091717151058500_jjag136-B21","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.immuni.2021.07.004","article-title":"Multiomics analyses reveal a critical role of selenium in controlling T cell differentiation in Crohn\u2019s disease","volume":"54","author":"Huang","year":"2021","journal-title":"Immunity"},{"key":"2026091717151058500_jjag136-B22","doi-asserted-by":"publisher","first-page":"e2204269120","DOI":"10.1073\/pnas.2204269120","article-title":"Identification of a unique subset of tissue-resident memory CD4+ T cells in Crohn\u2019s disease","volume":"120","author":"Yokoi","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026091717151058500_jjag136-B23","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41467-021-22164-6","article-title":"Single-cell analyses of Crohn\u2019s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions","volume":"12","author":"Jaeger","year":"2021","journal-title":"Nat Commun"},{"key":"2026091717151058500_jjag136-B24","doi-asserted-by":"publisher","first-page":"eadx8474","DOI":"10.1126\/sciimmunol.adx8474","article-title":"Single-cell profiling reveals diverse \u03b3\u03b4 T cell subsets in ulcerative colitis","volume":"11","author":"Mayer","year":"2026","journal-title":"Sci Immunol"},{"key":"2026091717151058500_jjag136-B25","doi-asserted-by":"publisher","first-page":"101038","DOI":"10.1016\/j.xcrm.2023.101038","article-title":"The single-cell transcriptional landscape of innate and adaptive lymphocytes in pediatric-onset colitis","volume":"4","author":"Kokkinou","year":"2023","journal-title":"Cell Rep Med"},{"key":"2026091717151058500_jjag136-B26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.gastro.2020.04.074","article-title":"Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn\u2019s disease","volume":"159","author":"Mitsialis","year":"2020","journal-title":"Gastroenterology"},{"key":"2026091717151058500_jjag136-B27","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/s41591-020-1003-4","article-title":"Single-cell atlas of colonic CD8+ T cells in ulcerative colitis","volume":"26","author":"Corridoni","year":"2020","journal-title":"Nat Med"},{"key":"2026091717151058500_jjag136-B28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/ibd\/izaf275","article-title":"Mucosal B cell expansion and maturation contribute to colitis pathogenesis","volume":"32","author":"Fung","year":"2026","journal-title":"Inflamm Bowel Dis"},{"key":"2026091717151058500_jjag136-B29","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41591-022-01680-y","article-title":"Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity","volume":"28","author":"Uzzan","year":"2022","journal-title":"Nat Med"},{"key":"2026091717151058500_jjag136-B30","doi-asserted-by":"publisher","first-page":"nwaf009","DOI":"10.1093\/nsr\/nwaf009","article-title":"The multi-organ landscape of B cells highlights dysregulated memory B cell responses in Crohn\u2019s disease","volume":"12","author":"Chen","year":"2025","journal-title":"Natl Sci Rev"},{"key":"2026091717151058500_jjag136-B31","doi-asserted-by":"publisher","first-page":"e20220538","DOI":"10.1084\/jem.20220538","article-title":"Remodeling of colon plasma cell repertoire within ulcerative colitis patients","volume":"220","author":"Scheid","year":"2023","journal-title":"J Exp Med"},{"key":"2026091717151058500_jjag136-B32","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.immuni.2022.11.002","article-title":"B cell expansion hinders the stroma-epithelium regenerative cross talk during mucosal healing","volume":"55","author":"Frede","year":"2022","journal-title":"Immunity"},{"key":"2026091717151058500_jjag136-B33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.immuni.2023.01.002","article-title":"The landscape of immune dysregulation in Crohn\u2019s disease revealed through single-cell transcriptomic profiling in the ileum and colon","volume":"56","author":"Kong","year":"2023","journal-title":"Immunity"},{"key":"2026091717151058500_jjag136-B34","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","article-title":"Single-cell analysis of Crohn\u2019s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy","volume":"178","author":"Martin","year":"2019","journal-title":"Cell"},{"key":"2026091717151058500_jjag136-B35","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41591-021-01520-5","article-title":"IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies","volume":"27","author":"Friedrich","year":"2021","journal-title":"Nat Med"},{"key":"2026091717151058500_jjag136-B36","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1038\/s41467-023-40156-6","article-title":"Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease","volume":"14","author":"Garrido-Trigo","year":"2023","journal-title":"Nat Commun"},{"key":"2026091717151058500_jjag136-B37","doi-asserted-by":"publisher","first-page":"e173835","DOI":"10.1172\/JCI173835","article-title":"Intercellular interaction between FAP\u2009+\u2009fibroblasts and CD150+ inflammatory monocytes mediates fibrostenosis in Crohn\u2019s disease","volume":"134","author":"Ke","year":"2024","journal-title":"J Clin Invest"},{"key":"2026091717151058500_jjag136-B38","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.mucimm.2025.02.008","article-title":"Spatially separated epithelium-associated and lamina propria neutrophils present distinct functional identities in the inflamed colon mucosa","volume":"18","author":"Yalom","year":"2025","journal-title":"Mucosal Immunol"},{"key":"2026091717151058500_jjag136-B39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ajpath.2023.10.009","article-title":"Phenotypic and functional diversity of neutrophils in gut inflammation and cancer","volume":"194","author":"Sumagin","year":"2024","journal-title":"Am J Pathol"},{"key":"2026091717151058500_jjag136-B40","doi-asserted-by":"publisher","first-page":"101714","DOI":"10.1016\/j.jcmgh.2026.101714","article-title":"Repeated dextran sulfate sodium exposure elicits distinct immune responses reflecting human ulcerative colitis","volume":"20","author":"Manzanares","year":"2026","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B41","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2018.08.067","article-title":"Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease","volume":"175","author":"Kinchen","year":"2018","journal-title":"Cell"},{"key":"2026091717151058500_jjag136-B42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.medj.2022.05.002","article-title":"Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases","volume":"3","author":"Korsunsky","year":"2022","journal-title":"Med"},{"key":"2026091717151058500_jjag136-B43","doi-asserted-by":"publisher","first-page":"e3001532","DOI":"10.1371\/journal.pbio.3001532","article-title":"Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing","volume":"20","author":"Jasso","year":"2022","journal-title":"PLOS Biol"},{"key":"2026091717151058500_jjag136-B44","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41588-025-02225-y","article-title":"Single-cell and spatial transcriptomics of stricturing Crohn\u2019s disease highlights a fibrosis-associated network","volume":"57","author":"Kong","year":"2025","journal-title":"Nat Genet"},{"key":"2026091717151058500_jjag136-B45","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1053\/j.gastro.2023.07.014","article-title":"Stricturing Crohn\u2019s disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions","volume":"165","author":"Mukherjee","year":"2023","journal-title":"Gastroenterology"},{"key":"2026091717151058500_jjag136-B46","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3390\/biomedicines12081674","article-title":"Landscape of interactions between stromal and myeloid cells in ileal Crohn\u2019s disease; indications of an important role for fibroblast-derived CCL-2","volume":"12","author":"Dovrolis","year":"2024","journal-title":"Biomedicines"},{"key":"2026091717151058500_jjag136-B47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nm.4307","article-title":"Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor\u2013neutralizing therapy in patients with inflammatory bowel disease","volume":"23","author":"West","year":"2017","journal-title":"Nat Med"},{"key":"2026091717151058500_jjag136-B48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-025-04872-8","article-title":"Intestinal stem and progenitor cells exhibit distinct adaptive responses to inflammatory stress in IBD","volume":"17","author":"Balasubramanian","year":"2026","journal-title":"Stem Cell Res Ther"},{"key":"2026091717151058500_jjag136-B49","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.jcmgh.2022.02.005","article-title":"Single-cell analysis reveals unexpected cellular changes and transposon expression signatures in the colonic epithelium of treatment-na\u00efve adult Crohn\u2019s disease patients","volume":"13","author":"Kanke","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41586-019-0992-y","article-title":"Colonic epithelial cell diversity in health and inflammatory bowel disease","volume":"567","author":"Parikh","year":"2019","journal-title":"Nature"},{"key":"2026091717151058500_jjag136-B51","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12916-024-03710-7","article-title":"Hexokinase 2 expression in apical enterocytes correlates with inflammation severity in patients with inflammatory bowel disease","volume":"22","author":"Weber-Stiehl","year":"2024","journal-title":"BMC Med"},{"key":"2026091717151058500_jjag136-B52","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41423-024-01158-6","article-title":"Neutrophil-derived PAD4 induces citrullination of CKMT1 exacerbates mucosal inflammation in inflammatory bowel disease","volume":"21","author":"Wang","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"2026091717151058500_jjag136-B53","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.stemcr.2024.06.006","article-title":"JAK\/STAT signaling promotes the emergence of unique cell states in ulcerative colitis","volume":"19","author":"Maciag","year":"2024","journal-title":"Stem Cell Reports"},{"key":"2026091717151058500_jjag136-B54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.devcel.2020.11.010","article-title":"Single-cell sequencing of developing human gut reveals transcriptional links to childhood Crohn\u2019s Disease","volume":"55","author":"Elmentaite","year":"2020","journal-title":"Dev Cell"},{"key":"2026091717151058500_jjag136-B55","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-024-07571-1","article-title":"Single-cell integration reveals metaplasia in inflammatory gut diseases","volume":"635","author":"Oliver","year":"2024","journal-title":"Nature"},{"key":"2026091717151058500_jjag136-B56","doi-asserted-by":"publisher","first-page":"45269","DOI":"10.1038\/s41598-025-29727-3","article-title":"Senescence-related gene signatures in Crohn\u2019s disease: integrating bulk and single-cell RNA sequencing analysis","volume":"15","author":"Luo","year":"2025","journal-title":"Sci Rep"},{"key":"2026091717151058500_jjag136-B57","doi-asserted-by":"publisher","first-page":"e171783","DOI":"10.1172\/jci.insight.171783","article-title":"Altered inflammatory mucosal signatures within their spatial and cellular context during active ileal Crohn\u2019s disease","volume":"10","author":"Kolachala","year":"2025","journal-title":"JCI Insight"},{"key":"2026091717151058500_jjag136-B58","doi-asserted-by":"publisher","first-page":"e3715","DOI":"10.1002\/jgm.3715","article-title":"Single-cell analysis of Crohn\u2019s disease: unveiling heterogeneity and evaluating ustekinumab outcomes","volume":"26","author":"Li","year":"2024","journal-title":"J Gene Med"},{"key":"2026091717151058500_jjag136-B59","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/ecco-jcc\/jjw053","article-title":"Mechanism of action of anti-TNF therapy in inflammatory bowel disease","volume":"10","author":"Levin","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2026091717151058500_jjag136-B60","doi-asserted-by":"publisher","first-page":"9300","DOI":"10.3748\/wjg.v22.i42.9300","article-title":"Molecular mechanism of action of antitumor necrosis factor antibodies in inflammatory bowel diseases","volume":"22","author":"Billmeier","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2026091717151058500_jjag136-B61","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/gut.53.1.70","article-title":"Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn\u2019s disease","volume":"53","author":"Di Sabatino","year":"2004","journal-title":"Gut"},{"key":"2026091717151058500_jjag136-B62","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1186\/s12967-025-06909-1","article-title":"Single-cell RNA sequencing reveals the adverse role of cDC3s in the response of ulcerative colitis patients to anti-TNF-\u03b1 therapy","volume":"23","author":"Li","year":"2025","journal-title":"J Transl Med"},{"key":"2026091717151058500_jjag136-B63","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41590-024-01994-8","article-title":"A longitudinal single-cell atlas of antitumor necrosis factor treatment in inflammatory bowel disease","volume":"25","author":"Thomas","year":"2024","journal-title":"Nat Immunol"},{"key":"2026091717151058500_jjag136-B64","doi-asserted-by":"publisher","first-page":"RP91792","DOI":"10.7554\/eLife.91792.3","article-title":"Concerted changes in the pediatric single-cell intestinal ecosystem before and after anti-TNF blockade","volume":"12","author":"Zheng","year":"2026","journal-title":"Elife"},{"key":"2026091717151058500_jjag136-B65","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1124\/jpet.109.153973","article-title":"The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases","volume":"330","author":"Soler","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"2026091717151058500_jjag136-B66","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nrgastro.2013.246","article-title":"IBD in 2013: enriching the therapeutic armamentarium for IBD","volume":"11","author":"Danese","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B67","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/j.gastro.2024.09.021","article-title":"Multimodal profiling of peripheral blood identifies proliferating circulating effector CD4+ T cells as predictors for response to integrin \u03b14\u03b27\u2013blocking therapy in inflammatory bowel disease","volume":"168","author":"Horn","year":"2025","journal-title":"Gastroenterology"},{"key":"2026091717151058500_jjag136-B68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/gutjnl-2018-316023","article-title":"Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease","volume":"68","author":"Zeissig","year":"2019","journal-title":"Gut"},{"key":"2026091717151058500_jjag136-B69","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/s41467-024-45665-6","article-title":"Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis","volume":"15","author":"Mennillo","year":"2024","journal-title":"Nat Commun"},{"key":"2026091717151058500_jjag136-B70","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/ibd\/izad084","article-title":"Responsiveness to vedolizumab therapy in ulcerative colitis is associated with alterations in immune cell-cell communications","volume":"29","author":"Hsu","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"2026091717151058500_jjag136-B71","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/gutjnl-2021-324868","article-title":"Residual homing of \u03b14\u03b27-expressing \u03b21+ PI16+ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab","volume":"71","author":"Becker","year":"2022","journal-title":"Gut"},{"key":"2026091717151058500_jjag136-B72","doi-asserted-by":"publisher","first-page":"wrag028","DOI":"10.1093\/ismejo\/wrag028","article-title":"Gut microbial production of lithocholic acid reprograms pro-resolutive macrophages to enhance vedolizumab responsiveness via the TGR5\/FXR\u2013NF-\u03baB axis","volume":"20","author":"Han","year":"2026","journal-title":"ISME J"},{"key":"2026091717151058500_jjag136-B73","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41575-023-00768-1","article-title":"IL-12 and IL-23 pathway inhibition in inflammatory bowel disease","volume":"20","author":"Verstockt","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B74","doi-asserted-by":"publisher","first-page":"1322054","DOI":"10.3389\/fimmu.2024.1322054","article-title":"Research progress of Ustekinumab in the treatment of inflammatory bowel disease","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"2026091717151058500_jjag136-B75","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41588-026-02634-7","article-title":"Single-cell RNA sequencing of terminal ileal biopsies identifies signatures of Crohn\u2019s disease pathogenesis","volume":"58","author":"Krzak","year":"2026","journal-title":"Nat Genet"},{"key":"2026091717151058500_jjag136-B76","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/ibd\/izag059","article-title":"Ustekinumab resistance in individuals with ulcerative colitis is associated with an alteration of a subset of proinflammatory mucosal regulatory T cells","volume":"32","author":"Briggs","year":"2026","journal-title":"Inflamm Bowel Dis"},{"key":"2026091717151058500_jjag136-B77","doi-asserted-by":"publisher","first-page":"1476592","DOI":"10.3389\/fmed.2024.1476592","article-title":"Ustekinumab affects myofibroblast metabolism to alleviate intestinal fibrosis by targeting KDELC1 in Crohn\u2019s disease through multi-machine learning combined with single-cell sequencing analysis","volume":"11","author":"Ma","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"2026091717151058500_jjag136-B78","doi-asserted-by":"publisher","first-page":"e002153","DOI":"10.1136\/bmjgast-2025-002153","article-title":"Multiomic characterisation of the clinical efficacy of guselkumab induction therapy in ulcerative colitis","volume":"13","author":"Hart","year":"2026","journal-title":"BMJ Open Gastroenterol"},{"key":"2026091717151058500_jjag136-B79","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/S0140-6736(21)00666-8","article-title":"Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b\/3 double-blind, randomised, placebo-controlled trial","volume":"397","author":"Feagan","year":"2021","journal-title":"Lancet"},{"key":"2026091717151058500_jjag136-B80","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","article-title":"JAK-STAT pathway targeting for the treatment of inflammatory bowel disease","volume":"17","author":"Salas","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B81","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1136\/gutjnl-2019-318448","article-title":"JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?","volume":"68","author":"Danese","year":"2019","journal-title":"Gut"},{"key":"2026091717151058500_jjag136-B82","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1056\/NEJMoa2212728","article-title":"upadacitinib induction and maintenance therapy for Crohn\u2019s disease","volume":"388","author":"Loftus","year":"2023","journal-title":"N Engl J Med"},{"key":"2026091717151058500_jjag136-B83","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N Engl J Med"},{"key":"2026091717151058500_jjag136-B84","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1093\/ibd\/izab116","article-title":"Randomized controlled trial substudy of cell-specific mechanisms of janus kinase 1 inhibition with upadacitinib in the Crohn\u2019s disease intestinal mucosa: analysis from the CELEST study","volume":"27","author":"Aguilar","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2026091717151058500_jjag136-B85","doi-asserted-by":"publisher","first-page":"jjaf076","DOI":"10.1093\/ecco-jcc\/jjaf076","article-title":"Differential effects of tofacitinib on macrophage activation contribute to lack of response in ulcerative colitis patients","volume":"19","author":"Mel\u00f3n-Ardanaz","year":"2025","journal-title":"J Crohns Colitis"},{"key":"2026091717151058500_jjag136-B86","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/ibd\/izac246","article-title":"The clinical response of upadacitinib and risankizumab is associated with reduced inflammatory bowel disease anti-TNF-\u03b1 inadequate response mechanisms","volume":"29","author":"Wang","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"2026091717151058500_jjag136-B87","doi-asserted-by":"publisher","first-page":"1551017","DOI":"10.3389\/fimmu.2025.1551017","article-title":"An exploratory single-cell analysis of peripheral blood mononuclear cells from vedolizumab-treated Crohn\u2019s disease patients identifies response-associated differences among the plasmacytoid dendritic cells and classical monocytes","volume":"16","author":"Li Yim","year":"2025","journal-title":"Front Immunol"},{"key":"2026091717151058500_jjag136-B88","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.3390\/ijms22084190","article-title":"Type I interferon production of plasmacytoid dendritic cells under control","volume":"22","author":"Bencze","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026091717151058500_jjag136-B89","doi-asserted-by":"publisher","first-page":"gutjnl-2025","DOI":"10.1136\/gutjnl-2025-336246","article-title":"TL1A-activated T cells remodel the rectal mucosa in patients with Crohn\u2019s disease with perianal fistulising disease","author":"Gudi\u00f1o","year":"2025","journal-title":"Gut"},{"key":"2026091717151058500_jjag136-B90","doi-asserted-by":"publisher","first-page":"101636","DOI":"10.1016\/j.jcmgh.2025.101636","article-title":"A myeloid lineage signifying antitumor necrosis factor resistance in Crohn\u2019s disease","volume":"20","author":"Munasinghe","year":"2026","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B91","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.cgh.2019.08.030","article-title":"Expression levels of 4 genes in colon tissue might be used to predict which patients will enter endoscopic remission after vedolizumab therapy for inflammatory bowel diseases","volume":"18","author":"Verstockt","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B92","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/biomedicines13061398","article-title":"Integrated single-cell transcriptome analysis reveals novel insights into the role of opioid signaling in the pathophysiology of inflammatory bowel disease","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomedicines"},{"key":"2026091717151058500_jjag136-B93","doi-asserted-by":"publisher","first-page":"1597528","DOI":"10.3389\/fimmu.2025.1597528","article-title":"Multi-omics reveals efferocytosis-related hub genes as biomarkers for ustekinumab response in colitis","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"2026091717151058500_jjag136-B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000540939","article-title":"Identification of a novel activated NK-associated gene score associated with diagnosis and biological therapy response in ulcerative colitis","volume":"106","author":"Dong","year":"2025","journal-title":"Digestion"},{"key":"2026091717151058500_jjag136-B95","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.3390\/ijms24076054","article-title":"Single-cell sequencing-based validation of T cell-associated diagnostic model genes and drug response in Crohn\u2019s disease","volume":"24","author":"Dai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026091717151058500_jjag136-B96","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12916-023-02989-2","article-title":"Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-\u03baB pathway in Crohn\u2019s disease","volume":"21","author":"Zhou","year":"2023","journal-title":"BMC Med"},{"key":"2026091717151058500_jjag136-B97","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/pharmaceutics16060835","article-title":"Single-cell transcriptomic and targeted genomic profiling adjusted for inflammation and therapy bias reveal CRTAM and PLCB1 as novel hub genes for antitumor necrosis factor alpha therapy response in Crohn\u2019s disease","volume":"16","author":"Gorenjak","year":"2024","journal-title":"Pharmaceutics"},{"key":"2026091717151058500_jjag136-B98","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12967-025-07509-9","article-title":"CD74+CCL5+ effector CD8+ T cells drive mucosal inflammation and predict biologics response in inflammatory bowel disease","volume":"24","author":"Wu","year":"2026","journal-title":"J Transl Med"},{"key":"2026091717151058500_jjag136-B99","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","article-title":"From bulk, single-cell to spatial RNA sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int J Oral Sci"},{"key":"2026091717151058500_jjag136-B100","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1038\/s41467-020-16905-2","article-title":"Flexible experimental designs for valid single-cell RNA-sequencing experiments allowing batch effects correction","volume":"11","author":"Song","year":"2020","journal-title":"Nat Commun"},{"key":"2026091717151058500_jjag136-B101","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41592-023-02040-5","article-title":"Causal identification of single-cell experimental perturbation effects with CINEMA-OT","volume":"20","author":"Dong","year":"2023","journal-title":"Nat Methods"},{"key":"2026091717151058500_jjag136-B102","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1158\/0008-5472.CAN-24-0690","article-title":"Spatiotemporal profiling defines persistence and resistance dynamics during targeted treatment of melanoma","volume":"85","author":"Rubinstein","year":"2025","journal-title":"Cancer Res"},{"key":"2026091717151058500_jjag136-B103","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jgg.2023.03.011","article-title":"Spatially resolved transcriptomics: a comprehensive review of their technological advances, applications, and challenges","volume":"50","author":"Cheng","year":"2023","journal-title":"J Genet Genomics"},{"key":"2026091717151058500_jjag136-B104","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41580-024-00768-2","article-title":"Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics","volume":"26","author":"Gulati","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026091717151058500_jjag136-B105","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.cell.2016.11.038","article-title":"Perturb-Seq: dissecting molecular circuits with scalable single-cell RNA profiling of pooled genetic screens","volume":"167","author":"Dixit","year":"2016","journal-title":"Cell"},{"key":"2026091717151058500_jjag136-B106","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41586-023-06570-y","article-title":"Transcriptional linkage analysis with in vivo AAV-Perturb-seq","volume":"622","author":"Santinha","year":"2023","journal-title":"Nature"},{"key":"2026091717151058500_jjag136-B107","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13073-022-01112-z","article-title":"Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease","volume":"14","author":"Mishra","year":"2022","journal-title":"Genome Med"},{"key":"2026091717151058500_jjag136-B108","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41540-024-00395-9","article-title":"Longitudinal single-cell data informs deterministic modelling of inflammatory bowel disease","volume":"10","author":"Kilian","year":"2024","journal-title":"NPJ Syst Biol Appl"},{"key":"2026091717151058500_jjag136-B109","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41586-021-03852-1","article-title":"Cells of the human intestinal tract mapped across space and time","volume":"597","author":"Elmentaite","year":"2021","journal-title":"Nature"},{"key":"2026091717151058500_jjag136-B110","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41575-023-00784-1","article-title":"A roadmap for the human gut cell atlas","volume":"20","author":"Zilbauer","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026091717151058500_jjag136-B111","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s43588-023-00464-9","article-title":"Single-cell meta-analysis of inflammatory bowel disease with scIBD","volume":"3","author":"Nie","year":"2023","journal-title":"Nat Comput Sci"},{"key":"2026091717151058500_jjag136-B112","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s42256-025-01069-9","article-title":"Unifying multi-sample network inference from prior knowledge and omics data with CORNETO","volume":"7","author":"Rodriguez-Mier","year":"2025","journal-title":"Nat Mach Intell"},{"key":"2026091717151058500_jjag136-B113","doi-asserted-by":"publisher","DOI":"10.64898\/2026.04.28.721379","article-title":"A transcriptional patient map of systemic lupus erythematosus reveals disease-related multicellular immune programs conserved between blood and kidney","author":"Li\u00f1ares-Blanco","year":"2026","journal-title":"bioRxiv"},{"key":"2026091717151058500_jjag136-B114","doi-asserted-by":"publisher","first-page":"eadt0986","DOI":"10.1126\/scisignal.adt0986","article-title":"Decoding cytokine networks in ulcerative colitis to identify pathogenic mechanisms and therapeutic targets","volume":"19","author":"Olbei","year":"2026","journal-title":"Sci Signal"},{"key":"2026091717151058500_jjag136-B115","doi-asserted-by":"publisher","first-page":"14099","DOI":"10.3390\/ijms241814099","article-title":"Single-cell network-based drug repositioning for discovery of therapies against antitumor necrosis factor-resistant Crohn\u2019s Disease","volume":"24","author":"Kwak","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/20\/9\/jjag136\/71192618\/jjag136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/20\/9\/jjag136\/71192618\/jjag136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:15:18Z","timestamp":1789679718000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/doi\/10.1093\/ecco-jcc\/jjag136\/8812749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":115,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjag136","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9]]},"article-number":"jjag136"}}